← Insider buys

Heidi L Wagner has sold stock and made no open-market buys since Feb 2016

Director at Wave Life Sciences, Inc., and 1 other company

SEC CIK 0001655029 · Filings on SEC.gov ↗

$0Bought
$1.4MSold
NoneLast buy

Companies

Every filing

10 filings since Feb 2016, newest first

About Heidi L Wagner

Heidi L. Wagner, JD, is a corporate director and global government affairs executive who serves on the board of directors of Wave Life Sciences Ltd. (Nasdaq: WVE), where she is an independent director and chair of the Nominating and Corporate Governance Committee and a member of the Compensation Committee.( She was appointed to Wave Life Sciences’ board in 2019 as one of three new independent directors, adding deep expertise in government and payor relations to support the company’s clinical and preclinical genetic medicines pipeline.( Wagner has also been reported in securities and insider-trading databases as a director-level insider of Wave Life Sciences, reflecting her role in the company’s governance and equity programs.(

Wagner currently serves as Global Head of Government Affairs at ElevateBio, LLC, where she sits on the executive team and leads the company’s global government affairs function.( Previously, she was Senior Vice President, Government Affairs and Policy at Global Blood Therapeutics, Inc., and Senior Vice President of Global Government Affairs at Alexion Pharmaceuticals, Inc., positions in which she led funding negotiations and global payer strategy for rare disease therapies and directed broad legislative and regulatory portfolios across international, national, and local levels.( Earlier in her career, she held leadership roles at Genentech, Inc. and the Healthcare Leadership Council.( In addition to Wave Life Sciences, she serves or has served on several boards, including the University of Colorado Foundation, the American Kidney Fund, the Lieber Institute for Brain Development, and No Patient Left Behind, and is recognized as a health care policy executive and consultant with more than 25 years of experience in biotechnology, pharmaceutical, and public payer policy.( Wagner earned her JD from George Mason University School of Law and a BS in Journalism & Mass Communication from the University of Colorado Boulder.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.